In accordance with ASC 730-10-25-1 Research and Development, costs incurred in obtaining technology licenses are charged to research and development expense if the technology licensed has not reached technological feasibility and has no alternative future use. The assets purchased by the Company, Mustang, Checkpoint and Coronado SO require substantial completion of research and development, regulatory and marketing approval efforts in order to reach technological feasibility. Accordingly, the total purchase price of $7.4 million, broken out as follows, was reflected as Research and Development-licenses acquired in the Company’s Condensed Consolidated Statement of Operations for the three months ended March 31, 2015:

 

($ in thousands)		For the Three Months Ended March 31, 2015
Fortress:
EGFR inhibitors		$	1,000
IV Tramadol			2,000
Fortress Companies:
Mustang			2,260	(1)
Checkpoint			1,000
Coronado SO			1,179	(2)
Total		$	7,439